ZYDUSWELL · NSE
Zydus Wellness Limited
₹522.25
-4.38% (-₹23.9)
Prev. close
₹546.15
Volume
7,23,768
Delivery %
30.0%
As of
18 Sept 2026
Price history
Analyst sentiment
Analysts lean bullish
1 analyst stance · last 90 days · one per analyst
Trackable
1 · 1 bull / 0 neutral / 0 bear
Long-Horizon
none in window
Commentary
none in window
Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded
Analyst opinions
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Initiated coverage on Zydus Wellness with a 'buy' rating and a target price of ₹650 per share, implying a 23% upside. Th…” | IIFL Capital AnalysisIIFL Capital | Zydus Wellness | PENDING |
Fundamentals
About Zydus Wellness Limited
Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in Asia, the Middle East, Africa, the Oceania, Europe, and North America. It provides glucose powder under the Glucon-D brand; sugar substitute products under the Sugar Free Gold+, Sugar Free Natura, Sugar Free Green, and I'm lite brands; Milk-based nutrition drink products under the Complan brand; table spreads under the Nutralite brand; skin cleansing products under the Everyuth brand; hair color products under the Cuticolor brand; heat powder under the Nycil brand; and healthy eating products, such as snack bars, protein bars, breakfast cookies, and protein chips under the RiteBite brand. The company also offers plant-based supplements, vitamins and minerals, collagens, omegas, probiotics, and micronutrients for adults under the WeightWorld brand; health and wellness products, including multivitamin and vitamin D3 gummies, mushroom-based supplements, and other superfood supplements under the MaxMedix brand; and food supplements for dogs and cats under the Animigo brand. The company was formerly known as Carnation Nutra-Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is headquartered in Ahmedabad, India. Zydus Wellness Limited operates as a subsidiary of Zydus Lifesciences Limited.
Details
Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Mr. Tarun G. Arora
Headquarters
Ahmedabad
Employees
1,685
Website
zyduswellness.comExchange
View on NSE ↗Key stats
Market cap
₹16,615.94 Cr
P/E ratio (TTM)
88.5
Dividend yield
0.22%
EPS (TTM)
₹5.90
Beta (1Y · daily vs NIFTY 50)
0.56
Beta (5Y · monthly vs NIFTY 50)
0.48
Shares float
9.31 Cr
EPS · quarter ended Jun 2026
₹3.74
Financial Performance
01 · Financials
FY21 growth needs FY20 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹1,866.67 Cr | ₹2,009.10 Cr | ₹2,254.79 Cr | ₹2,327.80 Cr | ₹2,708.90 Cr | ₹3,961.00 Cr | |
| EBITDA | ₹221.17 Cr | ₹355.15 Cr | ₹331.96 Cr | ₹307.90 Cr | ₹399.20 Cr | ₹475.30 Cr |
| ₹118.73 Cr | ₹308.87 Cr | ₹310.40 Cr | ₹266.90 Cr | ₹346.90 Cr | ₹197.20 Cr | |
| Diluted EPS | ₹3.91 | ₹9.71 | ₹9.76 | ₹8.39 | ₹10.9 | ₹6.2 |
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹5,666.43 Cr | ₹5,692.18 Cr | ₹5,833.05 Cr | ₹6,148.40 Cr | ₹6,441.90 Cr | ₹10,307.80 Cr | |
| ₹550.40 Cr | ₹387.34 Cr | ₹297.30 Cr | ₹328.70 Cr | ₹188.30 Cr | ₹3,202.80 Cr | |
| Stockholders' equity | ₹4,567.79 Cr | ₹4,844.03 Cr | ₹5,122.65 Cr | ₹5,357.50 Cr | ₹5,671.60 Cr | ₹5,826.00 Cr |
Long-term debt, Current (short-term) debt, Others have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹286.51 Cr | ₹236.85 Cr | ₹91.71 Cr | ₹246.40 Cr | ₹380.00 Cr | ₹226.40 Cr | |
| Investing cash flow | ₹-10.41 Cr | ₹-58.93 Cr | ₹-84.84 Cr | ₹-177.70 Cr | ₹-223.60 Cr | ₹-2,909.90 Cr |
| ₹-216.21 Cr | ₹-233.82 Cr | ₹-138.49 Cr | ₹-25.70 Cr | ₹-186.30 Cr | ₹2,698.40 Cr | |
| Capital expenditure | ₹-19.66 Cr | ₹-75.44 Cr | ₹-44.96 Cr | ₹-28.50 Cr | ₹-66.30 Cr | ₹-101.70 Cr |
| End cash position | ₹252.72 Cr | — | ₹38.18 Cr | ₹80.00 Cr | ₹66.70 Cr | ₹110.60 Cr |
Debt issued, Debt repaid, End cash position have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
11 · Shareholding Pattern
NSE, quarterly
| Line item | Jun 21–Mar 22(4Q) | Jun 22 | Sep 22–Dec 22(2Q) | Mar 23 | Jun 23 | Sep 23 | Dec 23 | Mar 24–Dec 24(4Q) | Mar 25–Mar 26(5Q) | Jun 26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 64.82% | 65.14% | 65.35% | 66.45% | 67.10% | 68.54% | 69.15% | 69.62% | 69.63% | 69.64% |
| Public | 35.18% | 34.86% | 34.65% | 33.55% | 32.90% | 31.46% | 30.85% | 30.38% | 30.37% | 30.36% |
| Employee trusts | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.
12 · Peer Comparison
Consumer Defensive
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Hindustan Unilever Limited | ₹4.56 L Cr | ₹1,932 | 43.7 | 9.36 | 30.9% | 0.03 | +5.3% | -25.3% |
| ITC Limited | ₹3.34 L Cr | ₹262.3 | 16.8 | 4.60 | 28.5% | 0.03 | +4.8% | -36.3% |
| Nestle India Limited | ₹2.67 L Cr | ₹1,383.3 | 69.9 | 66.52 | 80.0% | 0.29 | +19.6% | +14.1% |
| Avenue Supermarts Limited | ₹2.42 L Cr | ₹3,749.9 | 79.4 | 9.89 | 12.1% | 0.10 | +16.0% | -21.2% |
| Varun Beverages Limited | ₹1.41 L Cr | ₹421.95 | 41.5 | 7.18 | 15.5% | 0.13 | +7.1% | -10.9% |
| Britannia Industries Limited | ₹1.20 L Cr | ₹4,982 | 45.7 | 23.58 | 49.6% | 0.27 | +7.5% | -18.3% |
| Marico Limited | ₹1.06 L Cr | ₹803.9 | 56.0 | 25.19 | 41.9% | 0.13 | +26.2% | +11.7% |
| TATA CONSUMER PRODUCTS LIMITED | ₹98,978.89 Cr | ₹1,013.7 | 60.4 | 4.54 | 7.1% | 0.13 | +15.2% | -10.8% |
| United Spirits Limited | ₹98,697.70 Cr | ₹1,371 | 58.5 | 11.02 | 20.5% | 0.05 | +7.8% | +3.3% |
| Godrej Consumer Products Limited | ₹89,334.52 Cr | ₹880 | 46.6 | 7.06 | 14.7% | 0.35 | +8.5% | -28.9% |
| Dabur India Limited | ₹67,765.15 Cr | ₹384.55 | 34.7 | 5.93 | 16.6% | 0.11 | +5.2% | -28.1% |
| Zydus Wellness Limited | ₹17,376.35 Cr | ₹522.25 | 92.6 | 2.98 | 3.4% | 0.55 | +46.4% | +0.3% |
Ranked by market cap within Consumer Defensive, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 28
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Index membership
17 indices
NSE weights are a free-float market-cap-share estimate, not NSE’s own published (and sometimes capped) index weight. BSE weights are BSE’s own published index weight, not an estimate. Indices without weight data are listed without one, in alphabetical order after the weighted ones.